Clinical guidance for COVID-19
COVID-19 updates
The Academy’s Ad Hoc Task Force on COVID-19 is monitoring pandemic developments daily, assessing the impact on practices, and providing guidance most relevant to dermatologists. The most current information is being posted to these pages as we have it. Check back for updates.
Access Academy resources designed to answer common dermatology questions during the COVID-19 pandemic.
Review steps you should take to protect yourself, your staff, and your patients.
Access Academy advice and FDA guidance on conserving supplies of PPE and other medical supplies.
Review information and documents on continuing immunosuppressive therapies, including biologics, during the COVID-19 pandemic.
Read FDA guidance on flexibility in meeting iPLEDGE requirements during the emergency.
Access Academy statements and publications on COVID-19, including DermWorld and JAAD articles.
Wondering what guidance other organizations are providing? The AAD has assembled links to guidance from the AMA and other organizations.
Dermatology-specific changes to prior authorization policies due to COVID-19.
The AAD has developed guidance on individual and mass skin cancer screenings during the pandemic. Download the PDF.
Navigate the Coronavirus Resource Center
All content solely developed by the American Academy of Dermatology
Supported by:
